Literature DB >> 3726114

Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR.

J H Simon, S L Holtås, R B Schiffer, R A Rudick, R M Herndon, D K Kido, R Utz.   

Abstract

Examination with magnetic resonance imaging of 40 patients with confirmed diagnoses of multiple sclerosis showed that corpus callosum involvement is common. Thirty percent of the patients had focal callosal lesions similar to those described in the pathology literature. Long, inner callosal-subcallosal lesions were found in 55% of patients. These lesions had signal characteristics similar to those of noncallosal periventricular lesions. Diffuse moderate to severe atrophy of the corpus callosum was noted in 40% of patients, with one exception concurrent with inner callosal lesions. The nature of the inner callosal lesions is not known, since these lesions are not typically described in the literature. These lesions may represent demyelination or increased water content and may be the precursor to atrophy that progresses from the ependymal surface toward the outer fibers of the corpus callosum.

Entities:  

Mesh:

Year:  1986        PMID: 3726114     DOI: 10.1148/radiology.160.2.3726114

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  The ependymal "Dot-Dash" sign: an MR imaging finding of early multiple sclerosis.

Authors:  Christopher J Lisanti; Patrick Asbach; William G Bradley
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

Review 2.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

3.  Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.

Authors:  F J Barkhof; M Elton; J Lindeboom; M W Tas; W F Schmidt; O R Hommes; C H Polman; A Kok; J Valk
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

4.  The callosal-septal interface lesion in multiple sclerosis: effect of sequence and imaging plane.

Authors:  A Jackson; J B Fitzgerald; J E Gillespie
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

5.  Corpus callosum index and long-term disability in multiple sclerosis patients.

Authors:  Ozgür Yaldizli; Ramin Atefy; Achim Gass; Dietrich Sturm; Stephanie Glassl; Barbara Tettenborn; Norman Putzki
Journal:  J Neurol       Date:  2010-03-03       Impact factor: 4.849

6.  Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Authors:  Sirio Cocozza; Gaia Olivo; Eleonora Riccio; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Silvia Migliaccio; Dario de Rosa; Sandro Feriozzi; Massimiliano Veroux; Yuri Battaglia; Daniela Concolino; Federico Pieruzzi; Antonino Tuttolomondo; Aurelio Caronia; Cinzia Valeria Russo; Roberta Lanzillo; Vincenzo Brescia Morra; Massimo Imbriaco; Arturo Brunetti; Enrico Tedeschi; Antonio Pisani
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

7.  Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.

Authors:  J L Dietemann; C Beigelman; L Rumbach; M Vouge; T Tajahmady; C Faubert; M Y Jeung; A Wackenheim
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

8.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.

Authors:  Gloria C Chiang; Soniya Pinto; Joseph P Comunale; Susan A Gauthier
Journal:  J Neuroimaging       Date:  2015-10-13       Impact factor: 2.486

9.  Balance of T1-weighted images before and after application of a paramagnetic substance (Gd-DTPA).

Authors:  W Müller; G Krämer; R G Röder; A Kühnert
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

10.  Corpus callosum damage and cognitive dysfunction in benign MS.

Authors:  Sarlota Mesaros; Maria A Rocca; Gianna Riccitelli; Elisabetta Pagani; Marco Rovaris; Domenico Caputo; Angelo Ghezzi; Ruggero Capra; Antonio Bertolotto; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.